Predictive Health Symposium 2007

A distinguished field of national healthcare leaders and biomedical scientists participated in the third annual Emory/Georgia Tech Predictive Health Symposium December 17 and 18, 2007, in Atlanta. The symposium featured the latest advances in defining and measuring health, discovering health biomarkers, identifying interventions to optimize health and applying new knowledge to individuals and populations world-wide. Enjoy the videos available below or read the related press release.

You will need the RealNetworks RealPlayer plug-in to view the videos from the symposium over the Web.

Click name of speaker to view each talk.

2007

Day 1 - December 17, 2007

Welcome

Kenneth L. Brigham, MD
Associate Vice President, Predictive Health
Vice Chair for Research, Department of Medicine
Associate Director for Research, McKelvey Lung Transplant Center

Opening

Michael M. E. Johns, MD, Chancellor
Emory University

Welcome from Georgia Tech

Gary Schuster, PhD, Provost
Georgia Institute of Technology

Welcome from Emory

James Wagner, PhD, President
Emory University

Keynote Lecture:
Genetic Protection from Coronary Artery Disease

Helen H. Hobbs, MD (Introduced by Dr. Stephen Warren)
Investigator, Howard Hughes Medical Institute
Professor of Internal Medicine and Molecular Genetics
University of Texas Southwestern Medical Center

Part One:
Defining and Measuring Health

Introduction
Michelle Lampl, PhD, MD, Chair

What is Population Health?
David A. Kindig, MD, PhD
University of Wisconsin
Department of Population Health Science

Childhood Health Risks Predict Lifetime Health Risks
William H. Dietz, MD, PhD
Centers for Disease Control and Prevention

Disease in a Dish: Inconvenient Truths in Translation
Marie E. Csete, MD, PhD
Associate Profess or
Department of Anesthesiology
Emory University

Discussion with Questions & Answers
Panel of speakers.

Part Two:
Discovering Optimal Markers of Health

Introduction
Mark Bouzyk, PhD, Chair

Genome Wide Association Studies: Hunting for Genes in the New Millennium
Teri Manolio, MD, PhD
Director, Office of Population Genomics
Senior Advisor to the Director , NHGRI, for Population Genomics
National Human Genome Research Institute

Glycomics of Human Diseases - Functions and Malfunctions of Complex Carbohydrates
Richard D. Cummings, PhD
William Patterson Timmie Professor and Chair, Department of Biochemistry
Emory University

Discovering Optimal Markers of Health - A lipidomics perspective
Alfred H. Merrill, Jr., PhD
Professor and Smithgall Institute Chair in Molecular Cell Biology
Georgia Institute of Technology

Discussion with Question and Answers
Panel of speakers

Predictive Health: The Emory-Georgia Tech Initiative
Kenneth L. Brigham, MD
Associate Vice President, Predictive Health
Vice Chair for Research, Department of Medicine
Associate Director for Research, McKelvey Lung Transplant Center

Lessons from Day 1
Michael M.E. Johns, MD, Chancel/or
Emory University

Day 2 - December 18, 2007

Opening

Fred Sanfilippo, MD, PhD
CEO, Woodruff Health Sciences Center
Executive Vice President for Health Affairs
Chairman of the Board , Emory Healthcare

Keynote Lectures:
Individual Medicine: Cornerstone of a Health and Healthcare System

Denis A. Cortese, MD (Introduced by Dr. Michael Johns)
President
CEO of Mayo Clinic

Genomic Medicine: The Next Manhattan Project
Jeff Balser, MD, PhD (Introduced by Dr. Fred Sanfilippo)
Associate Vice-Chancellor for Research
Vanderbilt University

Part Three:
Identifying Interventions to Optimize Health

Introduction
Sue K. Donaldson, PhD
Distinguished Professor, School of Nursing
Emory University

Nutrigenetics and Nutrigenomics: Emerging opportunities for personlized nutrition with expanded newborn screening
Rani H. Singh PhD,RD
Associate Professor
Director, Emory Genetics Metabolic Nutrition Program
Department of Human Genetics

Can We Identify the Impact of Interventions on Population Health?
Jonathan M. Samet, MD, MS
Chairman; Jacob I and Irene B. Fabrikant Professor in Health, Risk and Society
Johns Hopkins Univerity

Breaking the cycle: Understanding how social inequities increase disease risk
Mark E. Wilson, PhD
Yerkes National Primate Research Center
Emory University

Discussion with Questions and Answers
Panel with speakers.

Part Four:
Determining How to Apply New Knowledge to Individuals and Populations World-wide

Introduction
Leader: Muin Khoury

Developing the evidence base for applying genomic applications to predict health and prevent disease
Linda Bradley, PhD
Geneticist , Team Leader
National Office of Public Health Genomics,
Centers for Disease Control and Prevention

Using Genetic information to effect behavior change
Colleen M. McBride, PhD
National Institutes of Health
Chief & Senior Investigator, Social and Behavioral Research Branch
Head, Public Health Genomics Section

Can newborn screening be used to define and predict health? Challenges and Opportunities
Paul M. Fernhoff, MD, FAAP, FACMG
Associate Professor of Human Genetics and Pediatrics
Emory University

Discussion with Questions and Answers
Panel of Speakers

Lessons from Day 2 and Symposium Closing Remarks
Fred Sanfilippo, MD, PhD
CEO, Woodruff Health Sciences Center
Executive Vice President for Health Affairs
Chairman of the Board, Emory Healthcare

Last Update: 01/17/2008